Accelerate Diagnostics Performance
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
The firm shows a Beta (market volatility) of 0.72, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Accelerate Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Accelerate Diagnostics is expected to be smaller as well. Accelerate Diagnostics right now shows a risk of 0.0%. Please confirm Accelerate Diagnostics total risk alpha, as well as the relationship between the kurtosis and market facilitation index , to decide if Accelerate Diagnostics will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Accelerate Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Accelerate Diagnostics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Accelerate |
Accelerate Diagnostics Relative Risk vs. Return Landscape
If you would invest 4.00 in Accelerate Diagnostics on November 7, 2025 and sell it today you would earn a total of 0.00 from holding Accelerate Diagnostics or generate 0.0% return on investment over 90 days. Accelerate Diagnostics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Accelerate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Accelerate Diagnostics Target Price Odds to finish over Current Price
The tendency of Accelerate Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.04 | 90 days | 0.04 | about 99.0 |
Based on a normal probability distribution, the odds of Accelerate Diagnostics to move above the current price in 90 days from now is about 99.0 (This Accelerate Diagnostics probability density function shows the probability of Accelerate Stock to fall within a particular range of prices over 90 days) .
Accelerate Diagnostics Price Density |
| Price |
Predictive Modules for Accelerate Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Accelerate Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accelerate Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Accelerate Diagnostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Accelerate Diagnostics is not an exception. The market had few large corrections towards the Accelerate Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Accelerate Diagnostics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Accelerate Diagnostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -3.7 | |
β | Beta against Dow Jones | 0.72 | |
σ | Overall volatility | 0.34 | |
Ir | Information ratio | -0.29 |
Accelerate Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Accelerate Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Accelerate Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Accelerate Diagnostics is not yet fully synchronised with the market data | |
| Accelerate Diagnostics has some characteristics of a very speculative penny stock | |
| Accelerate Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 11.7 M. Net Loss for the year was (50.05 M) with profit before overhead, payroll, taxes, and interest of 2.7 M. | |
| Accelerate Diagnostics currently holds about 36.77 M in cash with (24.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company shares are held by company insiders |
Accelerate Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Accelerate Stock often depends not only on the future outlook of the current and potential Accelerate Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Accelerate Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.3 M | |
| Cash And Short Term Investments | 16.3 M |
Accelerate Diagnostics Fundamentals Growth
Accelerate Stock prices reflect investors' perceptions of the future prospects and financial health of Accelerate Diagnostics, and Accelerate Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Accelerate Stock performance.
| Return On Asset | -0.74 | |||
| Operating Margin | (2.82) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 25.29 M | |||
| Price To Earning | (15.18) X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 11.7 M | |||
| EBITDA | (33.57 M) | |||
| Cash And Equivalents | 36.77 M | |||
| Cash Per Share | 0.45 X | |||
| Total Debt | 66.58 M | |||
| Debt To Equity | 2.76 % | |||
| Book Value Per Share | (2.23) X | |||
| Cash Flow From Operations | (24.19 M) | |||
| Earnings Per Share | (2.15) X | |||
| Total Asset | 28.56 M | |||
| Retained Earnings | (718.9 M) | |||
| Current Asset | 91.68 M | |||
| Current Liabilities | 4.45 M | |||
About Accelerate Diagnostics Performance
Evaluating Accelerate Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Accelerate Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Accelerate Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. Accelerate Diagnosti operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 220 people.Things to note about Accelerate Diagnostics performance evaluation
Checking the ongoing alerts about Accelerate Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Accelerate Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Accelerate Diagnostics is not yet fully synchronised with the market data | |
| Accelerate Diagnostics has some characteristics of a very speculative penny stock | |
| Accelerate Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 11.7 M. Net Loss for the year was (50.05 M) with profit before overhead, payroll, taxes, and interest of 2.7 M. | |
| Accelerate Diagnostics currently holds about 36.77 M in cash with (24.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company shares are held by company insiders |
- Analyzing Accelerate Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Accelerate Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Accelerate Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Accelerate Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Accelerate Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Accelerate Diagnostics' stock. These opinions can provide insight into Accelerate Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |